The metallo-␤-lactamase gene, ccrA, from Bacteroides fragilis is functionally expressed in Escherichia coli only in the presence of a genomic mutation in iarA or iarB (increased ampicillin resistance), identified in this study as dsbA or dsbB, respectively. DsbA and DsbB are components of a periplasmic protein disulfide bondcatalyzing system. Data indicated that DsbA interacted with CcrA, creating aberrant disulfide bond linkages that render CcrA proteolytically unstable. Mutations in dsbA or dsbB permissive for CcrA expression eliminated or greatly reduced DsbA activity, allowing CcrA to assume a disulfide bond-free and proteolytically stable conformation.
Expression of foreign proteins in Escherichia coli is not always successful. Multiple steps are required for the functional expression of a protein, including transcription, translation, translocation and processing, and correct secondary and tertiary folding. Inefficiency at any one of these steps may severely impair functional expression. Expression of the metallo-␤-lactamase, CcrA, from Bacteroides fragilis is inefficient in a wildtype E. coli strain (18, 19) . However, the level of functional expression increases greatly when the cells harbor a chromosomal mutation mapping to one of two E. coli chromosomal locations. These mutations were designated iar mutations, for increased ampicillin resistance (19) , and fell into two distinct classes on the basis of the chromosomal location of the mutant alleles. Class I and class II mutations have been designated to lie within the iarA locus and the iarB locus, identified here as dsbA and dsbB, respectively (1, 4, 5, 9, 15, 17) (see below). The mechanism by which a mutation in dsbA or dsbB, a gene encoding a component of a disulfide bond-catalyzing system (3), yielded increased ␤-lactamase activity is the focus of this study.
Identification of block in expression of CcrA. The dsb mutations studied here bestow to cells harboring ccrA the phenotype of increased ampicillin resistance. E. coli dsbA or dsbB strains were 8-to 16-fold less susceptible to ampicillin than wild-type strains as determined by measurement of the MIC of ampicillin (19) . It was demonstrated previously that this difference in ampicillin susceptibility is the result of increased ␤-lactamase activity in the dsb mutant strains (19) .
The block in CcrA expression was determined to be a posttranslational event. Although replacement of the ccrA promoter with the lacUV5 promoter (12) resulted in an increase in the basal level of ␤-lactamase activity, the presence of a dsbA or dsbB mutation still gave an 8-to 16-fold increase in the level of ampicillin susceptibility (data not shown). Similarly, replacement of the ccrA promoter and the signal sequence with the lacUV5 promoter and signal sequence-coding region from malE, encoding the periplasmic maltose-binding protein (8, 21) , also did not relieve the dsb effect on ccrA expression (data not shown). Therefore, the dsb mutations functioned at a step after transcription, translation, and the early steps in signal sequence recognition and entrance into the export pathway.
Identification of increased ampicillin resistance mutations as mutations in dsbA and dsbB. The class I and class II mutations were mapped by P1 cotransduction (14, 25) to 25.5 and 87 min on the E. coli K-12 chromosome, respectively (data not shown). When the locations were initially determined, no genes had been identified within either of the two regions (2) whose function would suggest a possible mechanism for the observed increase in ␤-lactamase activity. Therefore, the class I and class II loci were cloned.
The wild-type class II locus, iarB, was cloned by screening for complementation of the ␤-lactamase-positive phenotype caused by the iarB1 mutation. From total chromosomal DNA cloned into pACYC184 (7, 23) , a 9-kb BamHI fragment which, when transformed into a CcrA-expressing cell line, bestowed a ␤-lactamase-negative phenotype was identified. This pACYC184 (7, 23) plasmid derivative was designated pCLLiarB. The class I locus, iarA, was cloned following inactivation of the gene by Tn10 insertion (10, 24) , which resulted in a ␤-lactamase-positive phenotype. The locus was then cloned as two EcoRI fragments into pUC119 (26) , by using radioactive probes to Tn10 to identify it within a genomic bank (data not shown). DNA sequence analysis of the two clones and homology searches were performed by using the computer program DNAStar (DNASTAR, Inc., Madison, Wis.). The deduced amino acid sequences of the two genes were compared with sequences in the Swiss Protein Data Bank (release 80) by using the Pearson and Lipman algorithm (16) . Both the DNA and amino acid sequence analyses confirmed that iarA was dsbA and that iarB was dsbB (1, 4, 5, 9, 15, 17) . Analysis of several dsbA and dsbB mutant alleles (data not shown) indicated that these mutations were null mutations in either dsbA or dsbB.
The CcrA protein has an increased half-life in a dsb mutant strain. The level of translation and the half-life of CcrA were examined in dsbA1, dsbB1, and wild-type derivatives of MC4100 (6) . Cell cultures grown to mid-log phase in M63 glucose were pulse labeled (1 min) with [ 35 S]methionine (22 Ci/ml, Ͼ1,000 mCi/mmol; New England Nuclear, Boston, Mass.). The incorporation of radiolabel was terminated by chasing with cold, unlabeled methionine (21) . At various times postchase, an aliquot of the culture was removed and precipitated with cold trichloroacetic acid (final concentration, 5%). The precipitate was harvested, washed with acetone, and solubilized as described previously (21) . Radiolabeled CcrA was analyzed by immunoprecipitation with rabbit polyclonal antiserum prepared against purified protein (22) , followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (11) and autoradiography. The amounts of CcrA produced in a dsb ϩ strain and a dsbA1 or dsbB1 strain were comparable (Fig. 1, compare lanes labeled 30Љ) ; however, the half-lives of the CcrA proteins were significantly different. When CcrA was expressed in a dsb ϩ strain, the average halflife for CcrA was less than or equal to 5 min (Fig. 1) . Densitometry analysis using a GS300 scanning densitometer (Hoefer Scientific Instruments, San Francisco, Calif.) indicated that there were two populations of CcrA present in the dsb ϩ strains; the majority had a very short half-life, while a minor population had a long half-life similar to that of CcrA produced in a dsb mutant strain. When CcrA was expressed in either a dsbA1 or dsbB1 strain, only one CcrA population was observed. This population had a half-life of 15 to 30 min (Fig.  1) . Thus, the block in ␤-lactamase expression was indeed a posttranslational event, with rapid proteolysis being a possible contributing factor to the low levels of enzymatic activity.
Of additional interest is the observation that there is more stable CcrA precursor present in the dsb mutant strains than in the wild-type strains. This suggests that the dsb mutations may directly or indirectly affect signal sequence processing. It is unclear whether this inhibition is CcrA specific or of a more general nature.
Determination of reduced state of CcrA. CcrA contains three cysteine residues, one of which is proposed to participate in Zn 2ϩ binding (18) . Since disruption of dsbA resulted in a ␤-lactamase-positive phenotype, it was hypothesized that DsbA was interacting with CcrA, creating aberrant disulfide bonds. To determine if this was a feasible hypothesis, the reduced state of the three cysteine residues in enzymatically active recombinant CcrA was determined. Reaction of native or denatured CcrA with 5,5Ј-dithiobis(2 nitrobenzoic acid) (DTNB) (13, 29) indicated the presence of three free cysteine residues (data not shown). This was confirmed by reaction of CcrA with iodoacetamide followed by molecular weight determination (data not shown). Thus, in enzymatically active CcrA, none of the cysteine residues were disulfide bonded.
Western analysis of CcrA. Western (immunoblot) analysis of CcrA in whole-cell extracts prepared from dsb ϩ , dsbA1, and dsbB1 derivatives of MC1061 (6) or MC4100 (6) was performed. Cell extracts were prepared from mid-logarithmicphase cultures. The cells were harvested, resuspended in sample buffer with or without ␤-mercaptoethanol (11), and placed in a boiling water bath for 5 min to disrupt the cells. These extracts were subjected to SDS-11% PAGE (11) . The proteins were transferred from the polyacrylamide gel to a nitrocellulose filter by using an LKB Multiphor II system. Western analysis was done with rabbit polyclonal anti-CcrA antiserum and the ECL Western blotting chemiluminescent detection system (Amersham Corporation, Arlington Heights, Ill). CcrA was expressed from either the B. fragilis IS942 promoter (20) or the lacUV5 promoter (12) .
When the cell extracts were prepared and maintained under reducing conditions, two discrete CcrA protein bands, migrating in the gel at the positions of the mature and precursor (with a signal sequence) proteins, were observed. This was the case for CcrA from both wild-type and dsb mutant strains. There was, however, notably less CcrA in the extracts prepared from dsb ϩ strains. This correlated with the shorter half-life of CcrA in a dsb ϩ background. Although the level of CcrA expressed from the IS942 promoter was lower than that expressed from the lacUV5 promoter, the relative levels of CcrA expressed from each promoter were the same for all the dsb strains.
In contrast, the CcrA-banding patterns were strikingly different when CcrA was expressed from the lacUV5 promoter in a wild-type or dsb mutant strain and the cell extracts were prepared under nonreducing conditions. Western analysis of extracts prepared from dsb ϩ cells revealed only a very small amount of CcrA migrating at the expected position on the gel, less than that seen with the identical sample processed under reducing conditions. In addition, significantly more slowly migrating forms that reacted with the antibody appeared, as both discrete bands and smudges or streaks on the gel (Fig. 2, lanes  11 and 15) . Similar more slowly migrating forms were not seen in the nonreduced extracts prepared from dsbA1 or dsbB1 strains. These more slowly migrating forms corresponded to CcrA proteins disulfide bonded by DsbA either to themselves or to another protein(s); the smudging or band trailing was probably the result of proteolysis of these aberrant forms of CcrA.
We have demonstrated that the block in functional expression of CcrA in E. coli is a posttranslational event, independent of any promoter recognition or translocation problems. Effective expression of CcrA required a chromosomal mutation at one of two loci, identified in this work to be dsbA and dsbB. The presence of functional DsbA and DsbB proteins resulted in the creation of aberrant disulfide bonds that greatly affected the half-life of CcrA and perhaps its enzymatic activity. This cannot be overcome by growing E. coli in a reduced environment; a dsbA mutation was still required for functional expression of CcrA when E. coli was grown anaerobically (data not shown).
It has been demonstrated that DsbA can facilitate the formation of correct disulfide bond linkages in foreign proteins both in vitro and in vivo (1, 5, 9, 27, 28) . However, this is the first report of DsbA catalyzing the formation of aberrant disulfide bonds in a protein. eign proteins such as proteins from anaerobes or proteins that naturally reside in a reduced environment.
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FIG. 2. Western analysis of
CcrA under reducing and nonreducing conditions. Western analysis of whole-cell extracts prepared from MC1061 (6) wildtype, iarA1 (dsbA1), and iarB1 (dsbB1) strains was performed with CcrA expressed from either an IS942 promoter (20) or the lacUV5 promoter (12) . CcrA was identified by using anti-CcrA polyclonal rabbit antibody (22) and visualized by chemiluminescence with X-ray film. Lanes 1 to 8 contain whole-cell extracts prepared under reducing conditions, while lanes 9 to 16 contain the same extracts prepared under nonreducing conditions. The position of mature CcrA protein is indicated by the arrowhead. An additional band migrating more slowly than mature CcrA and running at the position of precursor CcrA, with the signal sequence attached, is often seen in cell extracts prepared from cells producing higher levels of CcrA. A set of five strong and several weak background bands is always seen with all E. coli cellular extracts whether expressing CcrA or not (data not shown). These bands are consistent in intensity and are present in all 16 lanes of this figure. 
